Pharmacokinetic characterization of mangosteen (Garcinia mangostana) fruit extract standardized to α-mangostin in C57BL/6 mice

Nutrition Research

Volumn 34, Issue 4, 2014, Pages 336-345

  Petiwala, Sakina M ^a   Li, Gongbo ^a   Ramaiya, Atulkumar ^a   Kumar, Anoop ^a   Gill, Ravinder K ^a   Saksena, Seema ^a   Johnson, Jeremy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Absorption; C57BL 6 mice; Mangosteen; Pharmacokinetic; mangostin

Indexed keywords

ALPHA MANGOSTIN; GARCINIA MANGOSTANA EXTRACT; LIVER ENZYME; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; MANGOSTIN; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; FRUIT; GARCINIA MANGOSTANA; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; C57BL MOUSE; CHEMISTRY; DIET SUPPLEMENTATION; DRUG INACTIVATION; GASTROINTESTINAL TRACT; LIVER MICROSOME; METABOLISM; STANDARDS;

GARCINIA MANGOSTANA; MUS;

ANIMALS; DIETARY SUPPLEMENTS; FRUIT; GARCINIA MANGOSTANA; GASTROINTESTINAL TRACT; INACTIVATION, METABOLIC; MICE, INBRED C57BL; MICROSOMES, LIVER; PLANT EXTRACTS; XANTHONES;

EID: 84899650281     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.03.002     Document Type: Article

References (28)

1. Obolskiy D., Pischel I., Siriwatanametanon N., Heinrich M. Garcinia mangostana L. a phytochemical and pharmacological review. Phytother Res 2009, 23:1047-1065.
2. Pedraza-Chaverri J., Cardenas-Rodriguez N., Orozco-Ibarra M., Perez-Rojas J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 2008, 46:3227-3239.
3. Jung H.A., Su B.N., Keller W.J., Mehta R.G., Kinghorn A.D. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 2006, 54:2077-2082.
4. Kondo M., Zhang L., Ji H., Kou Y., Ou B. Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem 2009, 57:8788-8792.
5. Bumrungpert A., Kalpravidh R.W., Chitchumroonchokchai C., et al. Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J Nutr 2009, 139:1185-1191.
6. Bumrungpert A., Kalpravidh R.W., Chuang C.C., et al. Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J Nutr 2010, 140:842-847.
7. Chen L.G., Yang L.L., Wang C.C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 2008, 46:688-693.
8. Chomnawang M.T., Surassmo S., Nukoolkarn V.S., Gritsanapan W. Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria. J Ethnopharmacol 2005, 101:330-333.
9. Chomnawang M.T., Surassmo S., Wongsariya K., Bunyapraphatsara N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 2009, 80:102-104.
10. Dharmaratne H.R., Sakagami Y., Piyasena K.G., Thevanesam V. Antibacterial activity of xanthones from Garcinia mangostana (L.) and their structure-activity relationship studies. Nat Prod Res 2013, 27:938-941.
11. Koh J.J., Qiu S., Zou H., et al. Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting. Biochim Biophys Acta 2013, 1828:834-844.
12. Ee G.C., Daud S., Izzaddin S.A., Rahmani M. Garcinia mangostana: a source of potential anti-cancer lead compounds against CEM-SS cell line. J Asian Nat Prod Res 2008, 10:475-479.
13. Johnson J.J., Petiwala S.M., Syed D.N., et al. alpha-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 2012, 33:413-419.
14. Liu Z., Antalek M., Nguyen L., et al. The effect of gartanin, a naturally occurring xanthone in mangosteen juice, on the mTOR pathway, autophagy, apoptosis, and the growth of human urinary bladder cancer cell lines. Nutr Cancer 2013, 65:68-77.
15. Matsumoto K., Akao Y., Ohguchi K., et al. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg Med Chem 2005, 13:6064-6069.
16. Devi Sampath P., Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007, 21:336-339.
17. Ramaiya A., Li G., Petiwala S.M., Johnson J.J. Single dose oral pharmacokinetic profile of alpha-mangostin in mice. Curr Drug Targets 2012, 13:1698-1704.
18. Udani J.K., Singh B.B., Barrett M.L., Singh V.J. Evaluation of Mangosteen juice blend on biomarkers of inflammation in obese subjects: a pilot, dose finding study. Nutr J 2009, 8:48-53.
19. Nabandith V., Suzui M., Morioka T., et al. Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac J Cancer Prev 2004, 5:433-438.
20. Li G., Thomas S., Johnson J.J. Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer. Front Pharmacol 2013, 4:80-83.
21. Li G., Petiwala S.M., Pierce D.R., Nonn L., Johnson J.J. Selective modulation of endoplasmic reticulum stress markers in prostate cancer cells by a standardized mangosteen fruit extract. PLoS One 2013, 8:e81572-e81580.
22. Johnson J.J., Syed D.N., Suh Y., et al. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 2010, 3:1112-1123.
23. Saksena S., Goyal S., Raheja G., et al. Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice. Am J Physiol Gastrointest Liver Physiol 2011, 300:G1115-G1123.
24. Johnson J.J., Nihal M., Siddiqui I.A., et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011, 55:1169-1176.
25. Lambert J.D., Hong J., Kim D.H., Mishin V.M., Yang C.S. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 1948-1952, 2004:134-152.
26. Shoba G., Joy D., Joseph T., et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998, 64:353-356.
27. Lin J.H. Dose-dependent pharmacokinetics: experimental observations and theoretical considerations. Biopharm Drug Dispos 1994, 15:1-31.
28. Nagao A. Absorption and function of dietary carotenoids. Forum Nutr 2009, 61:55-63.